Effectiveness of group-delivered therapy for insomnia
- Conditions
- InsomniaNervous System Diseases
- Registration Number
- ISRCTN16185698
- Lead Sponsor
- orwegian University of Science and Technology
- Brief Summary
2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36864376/ protocol (added 03/03/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 309
Inclusion criteria based on self-report and national registries:
1. Adults older than 18 years of age
2. Self-referred to the study
3. Insomnia Severity Index score of 12 or higher
Exclusion criteria based on self-report:
1. Bipolar disorder
2. Schizophrenia or other psychotic disorders
3. Personality disorders
4. Dementia and other neurodegenerative disorders
5. Heart surgery within the last 3 months
6. Untreated sleep apnea
7. Undergoing cancer treatment at the screening timepoint
8. Multiple sclerosis with an attack at screening timepoint
9. Adults without adequate skills in the Norwegian language to participate in the group-delivered course
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insomnia measured using the Insomnia Severity Index at baseline, 4 weeks, 3 months (primary measurement point), and 6 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.